# Liver Fibrosis Assessment in Diabetic Patients

> **NCT06694974** · NA · NOT_YET_RECRUITING · sponsor: **National Taiwan University Hospital** · enrollment: 540 (estimated)

## Conditions studied

- Type 2 Diabetes
- Metabolic Dysfunction-Associated Steatotic Liver Disease

## Interventions

- **BEHAVIORAL:** APP calculation for FIB-4
- **BEHAVIORAL:** Standard Care (in control arm)

## Key facts

- **NCT ID:** NCT06694974
- **Lead sponsor:** National Taiwan University Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-11-22
- **Primary completion:** 2025-12-31
- **Final completion:** 2025-12-31
- **Target enrollment:** 540 (ESTIMATED)
- **Last updated:** 2024-11-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06694974

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06694974, "Liver Fibrosis Assessment in Diabetic Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06694974. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*